CORV - カルディオ―ム・ファ―マ (Correvio Pharma Corp.)

CORVのニュース

   Correvio Pharma (CORV) Reports Q4 Loss, Misses Revenue Estimates  2020/03/30 18:25:02 Zacks Investment Research
Correvio (CORV) delivered earnings and revenue surprises of 23.08% and -1.66%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
   Will Correvio Pharma (CORV) Report Negative Q4 Earnings? What You Should Know  2020/03/04 17:30:29 Zacks Investment Research
Correvio (CORV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   CORREVIO INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm  2020/01/31 19:50:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (“Correvio” or the “Company”) (NASDAQ:CORV) of the February 10, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Correvio stock or options between October 23, 2018 and December 5, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/CORV.
   Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation  2020/01/02 17:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $CORV--Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation
   TOP RANKED ROSEN LAW FIRM Reminds Correvio Pharma Corp. Investors of Important Deadline in Securities Action– CORV  2019/12/24 16:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Correvio Pharma Corp. (NASDAQ: CORV) between October 23, 2018 and December 5, 2019, inclusive (the “Class Period”) of the important February 10, 2020 lead plaintiff deadline in securities class action. The lawsuit seeks to recover damages for Correvio investors under the federal securities laws. To join the Correvio class action, go to http://www.rosenlegal.com/cases-register-17
   Will Correvio Pharma (CORV) Report Negative Q4 Earnings? What You Should Know  2020/03/04 17:30:29 Zacks Investment Research
Correvio (CORV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   CORREVIO INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm  2020/01/31 19:50:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (“Correvio” or the “Company”) (NASDAQ:CORV) of the February 10, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Correvio stock or options between October 23, 2018 and December 5, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/CORV.
   Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation  2020/01/02 17:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $CORV--Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation
   TOP RANKED ROSEN LAW FIRM Reminds Correvio Pharma Corp. Investors of Important Deadline in Securities Action– CORV  2019/12/24 16:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Correvio Pharma Corp. (NASDAQ: CORV) between October 23, 2018 and December 5, 2019, inclusive (the “Class Period”) of the important February 10, 2020 lead plaintiff deadline in securities class action. The lawsuit seeks to recover damages for Correvio investors under the federal securities laws. To join the Correvio class action, go to http://www.rosenlegal.com/cases-register-17
   Correvio Pharma : Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events | MarketScreener  2019/12/24 13:01:04 MarketScreener
NASDAQ: CORV TSX: CORV VANCOUVER, Dec. 24, 2019 /PRNewswire/ - Correvio Pharma Corp. , a specialty pharmaceutical company focused on commercializing hospital drugs, today announced it… | December 24, 2019
   Will Correvio Pharma (CORV) Report Negative Q4 Earnings? What You Should Know  2020/03/04 17:30:29 Zacks Investment Research
Correvio (CORV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   CORREVIO INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm  2020/01/31 19:50:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (“Correvio” or the “Company”) (NASDAQ:CORV) of the February 10, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Correvio stock or options between October 23, 2018 and December 5, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/CORV.
   Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation  2020/01/02 17:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $CORV--Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation
   TOP RANKED ROSEN LAW FIRM Reminds Correvio Pharma Corp. Investors of Important Deadline in Securities Action– CORV  2019/12/24 16:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Correvio Pharma Corp. (NASDAQ: CORV) between October 23, 2018 and December 5, 2019, inclusive (the “Class Period”) of the important February 10, 2020 lead plaintiff deadline in securities class action. The lawsuit seeks to recover damages for Correvio investors under the federal securities laws. To join the Correvio class action, go to http://www.rosenlegal.com/cases-register-17
   Correvio Pharma : Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events | MarketScreener  2019/12/24 13:01:04 MarketScreener
NASDAQ: CORV TSX: CORV VANCOUVER, Dec. 24, 2019 /PRNewswire/ - Correvio Pharma Corp. , a specialty pharmaceutical company focused on commercializing hospital drugs, today announced it… | December 24, 2019

calendar